ProfileGDS4718 / 204634_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 84% 84% 83% 80% 85% 88% 87% 82% 81% 86% 87% 80% 87% 89% 86% 88% 87% 88% 87% 76% 83% 83% 83% 84% 85% 89% 85% 82% 83% 87% 85% 85% 79% 87% 79% 87% 85% 82% 82% 83% 84% 86% 79% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4271884
GSM549102patient 115, normal, homogenized [OPG study]8.3300584
GSM549104patient 119, normal, homogenized [OPG study]8.3059883
GSM549108patient 138, normal, homogenized [OPG study]7.76980
GSM549119patient 077, normal, homogenized [OPG study]8.4850385
GSM549133patient 032, cancer, homogenized [OPG study]8.973188
GSM549139patient 042, cancer, homogenized [OPG study]8.6990387
GSM549099patient 107, normal, homogenized [OPG study]8.0295782
GSM549109patient 139, normal, homogenized [OPG study]7.9311681
GSM549110patient 046, normal, homogenized [OPG study]8.6585586
GSM549114patient 063, normal, homogenized [OPG study]8.8868187
GSM549122patient 082, normal, homogenized [OPG study]7.8387980
GSM549134patient 033, cancer, homogenized [OPG study]8.697587
GSM549136patient 036, cancer, homogenized [OPG study]9.1703689
GSM549140patient 044, cancer, homogenized [OPG study]8.6882286
GSM549111patient 047, normal, homogenized [OPG study]8.940888
GSM549113patient 057, normal, homogenized [OPG study]8.8759487
GSM549132patient 031, cancer, homogenized [OPG study]8.7996888
GSM549137patient 038, cancer, homogenized [OPG study]8.7049787
GSM549142patient 047, cancer, homogenized [OPG study]7.2739776
GSM549100patient 110, normal, homogenized [OPG study]8.2007583
GSM549107patient 135, normal, homogenized [OPG study]8.1930183
GSM549115patient 068, normal, homogenized [OPG study]8.356883
GSM549116patient 072, normal, homogenized [OPG study]8.3599984
GSM549120patient 078, normal, homogenized [OPG study]8.4687185
GSM549131patient 030, cancer, homogenized [OPG study]9.1304789
GSM549118patient 074, normal, homogenized [OPG study]8.453585
GSM549129patient 027, cancer, homogenized [OPG study]8.1346482
GSM549123patient 088, normal, homogenized [OPG study]8.2026483
GSM549124patient 006, cancer, homogenized [OPG study]8.5716487
GSM549126patient 015, cancer, homogenized [OPG study]8.45685
GSM549128patient 025, cancer, homogenized [OPG study]8.531585
GSM549103patient 117, normal, homogenized [OPG study]7.5893379
GSM549117patient 073, normal, homogenized [OPG study]8.7952287
GSM549138patient 041, cancer, homogenized [OPG study]7.825979
GSM549141patient 045, cancer, homogenized [OPG study]8.8510787
GSM549130patient 028, cancer, homogenized [OPG study]8.3764485
GSM549101patient 111, normal, homogenized [OPG study]8.0822482
GSM549105patient 128, normal, homogenized [OPG study]7.9926682
GSM549106patient 134, normal, homogenized [OPG study]8.3713183
GSM549112patient 048, normal, homogenized [OPG study]8.3500484
GSM549125patient 011, cancer, homogenized [OPG study]8.5125186
GSM549127patient 024, cancer, homogenized [OPG study]7.8326879
GSM549135patient 035, cancer, homogenized [OPG study]8.8334287